- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01743183
Influence of Respiratory Muscle Training in Elderly Hypertensive Women With Respiratory Muscle Weakness
December 4, 2012 updated by: Patra-cia Angelica de Miranda Silva Nogueira, Universidade Federal do Rio Grande do Norte
This study aims to evaluate pulmonary function and respiratory muscle strength in a group of elderly women with hypertension before and after a respiratory muscle training.
Study Overview
Detailed Description
It is a respiratory muscle training using the Threshold for 5 weeks, with a load of 30% of maximal inspiratory pressure obtained in manometer for 30 minutes daily.
Furthermore, the assessment includes: test 6-minute walk, the quality of life questionnaire, MINICHAL, the IPAQ short version, manometer and spirometry.
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande do Norte
-
Natal, Rio Grande do Norte, Brazil
- Universidade Federal do Rio Grande do Norte
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- diagnosis of hypertension controlled by antihypertensive;
- aged between 60 and 80 years;
- absence of dementia or cognitive impairments that limit tests;
- absence of recent myocardial infarction;
- absence of musculoskeletal limitations that limit tests;
- availability of time on training days.
Exclusion Criteria:
- clinical instability;
- inability to perform any test.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: threshold
Held inspiratory muscle strengthening for 5 weeks with Threshold, charging 30% of maximal inspiratory pressure, 7 days a week, one supervised and unsupervised 6.
|
The load adjustment was done weekly by a single examiner.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
manovacuometry
Time Frame: 6 weeks
|
Evaluates indirectly respiratory muscle strength.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
---|---|
spirometry
|
Assesses lung function
|
Other Outcome Measures
Outcome Measure |
Measure Description |
---|---|
quality of life
|
Assesses the influence of hypertension on the quality of life of target
|
functional capacity
|
assesses the cardiopulmonary capacity at sub-maximal
|
IPAQ
|
assesses the level of physical activity
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Patrícia Nogueira, Universidade Federal do Rio Grande do Norte
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
October 1, 2012
Study Completion (Actual)
November 1, 2012
Study Registration Dates
First Submitted
November 12, 2012
First Submitted That Met QC Criteria
December 4, 2012
First Posted (Estimate)
December 6, 2012
Study Record Updates
Last Update Posted (Estimate)
December 6, 2012
Last Update Submitted That Met QC Criteria
December 4, 2012
Last Verified
December 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 05135912.8.0000.5537
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
Clinical Trials on Threshold
-
Universidade Federal de PernambucoCompleted
-
IRCCS San RaffaeleCompleted
-
Ospedali Riuniti TriesteCompleted
-
University of AarhusCompleted
-
University of ValenciaCompletedRotator Cuff TendinitisSpain
-
Guangzhou Institute of Respiratory DiseaseCompletedChronic Obstructive Pulmonary DiseaseChina
-
Biruni UniversityThe Scientific and Technological Research Council of TurkeyRecruiting
-
AGIR à DomUnknown
-
Shahid Beheshti University of Medical SciencesCompletedCOVID-19Iran, Islamic Republic of
-
Spaarne GasthuisRecruitingBronchiolitis | Lower Respiratory Tract Infection | Bronchial HyperreactivityNetherlands